304 related articles for article (PubMed ID: 15024133)
1. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.
Ravirajan CT; Wang Y; Matis LA; Papadaki L; Griffiths MH; Latchman DS; Isenberg DA
Rheumatology (Oxford); 2004 Apr; 43(4):442-7. PubMed ID: 15024133
[TBL] [Abstract][Full Text] [Related]
2. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
4. Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis.
Ravirajan CT; Rahman MA; Papadaki L; Griffiths MH; Kalsi J; Martin AC; Ehrenstein MR; Latchman DS; Isenberg DA
Eur J Immunol; 1998 Jan; 28(1):339-50. PubMed ID: 9485213
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity.
Mason LJ; Lambrianides A; Haley JD; Manson JJ; Latchman DS; Isenberg DA; Rahman A
Arthritis Res Ther; 2005; 7(5):R971-83. PubMed ID: 16207338
[TBL] [Abstract][Full Text] [Related]
7. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
8. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
[TBL] [Abstract][Full Text] [Related]
9. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
[TBL] [Abstract][Full Text] [Related]
10. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
12. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis.
Banda NK; Kraus D; Vondracek A; Huynh LH; Bendele A; Holers VM; Arend WP
Arthritis Rheum; 2002 Nov; 46(11):3065-75. PubMed ID: 12428251
[TBL] [Abstract][Full Text] [Related]
14. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
15. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
16. Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.
Kashihara N; Makino H; Szekanecz Z; Waltenbaugh CR; Kanwar YS
Lab Invest; 1992 Dec; 67(6):752-60. PubMed ID: 1460866
[TBL] [Abstract][Full Text] [Related]
17. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
18. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
19. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
Rodriguez W; Mold C; Kataranovski M; Hutt J; Marnell LL; Du Clos TW
Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]